Swisscanto Private Equity Investors With Purpose
![](/files/companies/Swisscanto%20Private%20Equity.png)
Swisscanto Private Equity invests in technology and healthtech growth companies in the late-stage venture/growth capital phase.
Investment Stage:
Late Stage Venture
Founded Date:
2018
Investor Type:
Innovation, Technology, and Research
Estimated Revenue:
$1B to $10B
Employee Number:
101-250
Industry:
Innovation, Technology, and Research
Technology:
Other type
Headquarters:
Zürich, Zurich, Switzerland